Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Ivabradine Administration on Clinical Outcome and Biomarkers of Decompensated Heart Failure

NCT03701880 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT03701880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03701880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Ivabradine Administration on Clinical Outcome and Biomarkers of Decompensated Heart Failure
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Unknown status
Start date
September 16, 2018
Completion date
December 23, 2019
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

decompensated heart failure, heart failure with reduced ejection fraction